Purple Biotech (PPBT) Acquisitions (2023)
Purple Biotech's (PPBT) quarterly Acquisitions came in at -$3.5 million in Q1 2023.
Analysis
Purple Biotech (PPBT) Acquisitions (2023) Analysis & Trends
Purple Biotech (PPBT) has reported Acquisitions for 1 consecutive years, with -$3.5 million the latest figure, recorded in Q1 2023.
- On a quarterly basis, Acquisitions changed N/A year-over-year to -$3.5 million in Q1 2023; TTM through Dec 2023 was -$3.5 million, a N/A change from a year earlier, with the FY2023 full-year figure at -$3.5 million, changed N/A from the prior year.
- Acquisitions was -$3.5 million for Q1 2023 at Purple Biotech.
- Over five years, Acquisitions peaked at -$3.5 million in Q1 2023 and troughed at -$3.5 million in Q1 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 11.21 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | Purple Biotech | 295,122.59 | 295,122.59 | - | - |